EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis

Mary Kathryn Vance, David A Cretella, Lori M Ward, Prakhar Vijayvargiya, Zerelda Esquer Garrigos, Mary Joyce B Wingler iD

Pharmacy · 13.04.2023 · 11 (2) · 74

DOI: 10.3390/pharmacy11020074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy, online erschienen am 13.04.2023. Verfasst von Mary Kathryn Vance und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Risk factors for extended-spectrum beta-lactamase (ESBL) infections could vary geographically. The purpose of this study was to identify local risk factors for ESBL production in patients with Gram-negative bacteremia. (2)

Methods

This retrospective observational study included adult patients admitted from January 2019 to July 2021 and had positive blood cultures for E. coli, K. pneumoniae, K. oxytoca, and P. mirabilis. Patients with ESBL infection were matched to a non-ESBL-producing infection with the same organism. (3)

Results

A total of 150 patients were included: 50 in the ESBL group and 100 in the non-ESBL group. Patients in the ESBL group had a longer length of stay (11 vs. 7 days, p < 0.001), but not increased mortality (14% vs. 15%, p = 0.87) Multivariate analysis identified the receipt of >1 antibiotic in the last 90 days as a risk factor for ESBL infection (OR = 3.448, 95% CI = 1.494–7.957; p = 0.004); (4)

Conclusions

Recent antimicrobial use was identified as an independent risk factors for ESBL-producing Enterobacterales infections. Knowledge of this risk may improve empirical therapy and reduce inappropriate use.

Schlagwörter

Stichwörter der Autor:innen

antibioticsbloodstream infectionextended-spectrum beta lactamase

Autor:innen und Institutionen

  • Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Antimicrobial Stewardship, University of Mississippi Medical Center, Jackson, MS 39216, USA.
  • Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.
  • Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS 39216, USA.

ORCID-Profile: Mary Joyce B Wingler

Zitieren

APA

Vance, M. K., Cretella, D. A., Ward, L. M., Vijayvargiya, P., Garrigos, Z. E., & Wingler, M. J. B. (2023). Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis. Pharmacy, 11(2), 74. https://doi.org/10.3390/pharmacy11020074

Vancouver

Vance MK, Cretella DA, Ward LM, Vijayvargiya P, Garrigos ZE, Wingler MJB. Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis. Pharmacy. 2023;11(2):74. doi:10.3390/pharmacy11020074

BibTeX
@article{Vance2023,
  author = {Vance, Mary Kathryn and Cretella, David A and Ward, Lori M and Vijayvargiya, Prakhar and Garrigos, Zerelda Esquer and Wingler, Mary Joyce B},
  title = {Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis},
  journal = {Pharmacy},
  year = {2023},
  volume = {11},
  number = {2},
  pages = {74},
  doi = {10.3390/pharmacy11020074}
}
Kostenlos starten →